Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CK0802 for Treatment of Steroid Refractory Graft vs. Host Disease (GVHD)

NCT07576699 is registered in ClinicalTrials.gov with Cellenkos, Inc. as lead sponsor.

NCT NCT07576699
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07576699 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CK0802 for Treatment of Steroid Refractory Graft vs. Host Disease (GVHD)
Lead sponsor
Cellenkos, Inc.
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
July 1, 2026
Completion date
June 30, 2029
Enrollment
12 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

steroid refractory graft versus host disease